Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice

Blood

Volumn 103, Issue 6, 2004, Pages 2196-2204

  Yuda, Hisamichi ^b   Adachi, Yukihiko ^b   Taguchi, Osamu ^b   Gabazza, Esteban C ^a   Hataji, Osamu ^b   Fujimoto, Hajime ^b   Tamaki, Shigenori ^b   Nishikubo, Kimiaki ^b   Fukudome, Kenji ^b   D'Alessandro Gabazza, Corina N ^b   Maruyama, Junko ^b   Izumizaki, Masahiko ^b   Iwase, Michiko ^b   Homma, Ikuo ^b   Inoue, Ryo ^b   Kamada, Haruhiko ^b   Hayashi, Tatsuya ^b   Kasper, Michael ^b   Lambrecht, Bart N ^b   Barnes, Peter J ^b   Suzuki, Koji ^b   more..

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CYTOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; OVALBUMIN; STAT6 PROTEIN; TH2 CYTOKINE; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH2 CELL;

EID: 12144291151     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-06-1980     Document Type: Article

References (41)

1. Burney PGJ. Epidemiologic trends. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, eds. Asthma. Philadelphia, PA: Lippincott Raven; 1997:35-47.
2. Busse WW, Lemanske RF. Asthma. N Engl J Med. 2001;344:350-362.
3. Barnes PJ. Therapeutic strategies for allergic diseases. Nature. 1999;402:B31-B37.
4. Barnes PJ, Hansel TT. The need for new therapy. In: Hansel TT, Barnes PJ, eds. New drugs for asthma, allergy and COPD. Basel, Switzerland: Karger;2001:2-5.
5. Suzuki K. Protein C. In: High KA, Robert HR, eds. Molecular Basis of Thrombosis and Hemostasis. Tokyo: Marcel Dekker; 1995:395-423.
6. Esmon CT, Gu JM, Xu J, Qu D, Stearns-Kurosawa DJ, Kurosawa S. Regulation and functions of the protein C anticoagulant pathway. Haematologica. 1999;84:363-368.
7. Kobayashi H, Gabazza EC, Taguchi O, et al. Protein C anticoagulant system in patients with interstitial lung disease. Am J Respir Crit Care Med. 1998;157:1850-1854.
8. Yasui H, Gabazza EC, Taguchi O, et al. Decreased protein C activation is associated with abnormal collagen turnover in the intraalveolar space of patients with interstitial lung disease. Clin Appl Thromb Hemost. 2000;6:202-205.
9. Hataji O, Taguchi O, Gabazza EC, Yuda H, Suzuki K, Adachi Y. Activation of protein C pathway in the airways. Lung. 2002;180:47-59.
10. Yasui H, Gabazza EC, Tamaki S, et al. Intratracheal administration of activated protein c inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med. 2001;163:1660-1668.
11. Gabazza EC, Taguchi O, Adachi Y. Bleomycin-induced lung fibrosis: the authors should have used another method to induce pulmonary lesions resembling human idiopathic pulmonary fibrosis [letter]. Am J Respir Crit Care Med. 2002;165:845-846.
12. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
13. Oka S, Gabazza EC, Taguchi Y, et al. Role of activated protein C in Helicobacter pylori-associated gastritis. Infect Immun. 2000;68:2863-2869.
14. Shimizu S, Gabazza EC, Taguchi O, et al. Activated protein C inhibits the expression of platelet-derived growth factor in the lung. Am J Respir Crit Care Med. 2003;167:1416-1426.
15. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanism modulating inflammation and apoptosis. J Biol Chem. 2001;276:11199-11203.
16. Fukudome K, Esmon CT. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). J Biol Chem. 1995;270:5571-5577.
17. Esmon CT, Xu J, Gu JM, et al. Endothelial protein C receptor. Thromb Haemost. 1999;82:251-258.
18. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerolised allergen. Thorax. 1998;53:849-856.
19. Hamelmann E, Schwarze J, Takeda K, et al. Non-invasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med. 1997;156:766-775.
20. Caver TE, O'Sullivan FX, Gold LI, Gresham HD. Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection. J Clin Invest. 1996;8:2496-2506.
21. Maruyama J, Yokochi A, Maruyama K, Nosaka S. Acetylcholine-induced endothelium-derived contracting factor in hypoxic pulmonary hypertensive rats. J Appl Physiol. 1999;86:1687-1695.
22. Shimizu S, Gabazza EC, Hayashi T, Ido M, Adachi Y, Suzuki K. Thrombin stimulates the expression of PDGF in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2000;279:L503-510.
23. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
24. Bonder CS, Dickensheets HL, Finlay-Jones JJ, Donnelly RP, Hart PH. Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production. J Immunol. 1998;160:4048-4056.
25. Chen XH, Patel BK, Wang LM, et al. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules. J Biol Chem. 1997;272:6556-6560.
26. Gabazza EC, Taguchi O, Tamaki S, et al. Thrombin in the airways of asthmatic patients. Lung. 1999;177:253-262.
27. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
28. Hauck RW, Schulz C, Schomig A, Hoffman RK, Panettieri RA Jr. Alpha-Thrombin stimulates contraction of human bronchial rings by activation of protease-activated receptors. Am J Physiol. 1999;1277:L22-L29.
29. Gabazza EC, Takeya H, Deguchi H, et al. Protein C activation in NIDDM patients. Diabetologia. 1996;39:1455-1461.
30. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS. Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest. 1993;91:1721-1730.
31. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296:1880-1882.
32. Ray A, Cohn L. Th2 cytokines and GATA-3 in asthma: new insights into the regulation of airway inflammation. J Clin Invest. 1999;104:985-993.
33. Shimoda K, van Deursen J, Sangster MY, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature. 1996;380:630-633.
34. Jiang H, Harris MB, Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol. 2000;105:1063-1670.
35. Yang L, Cohn L, Zhang DH, Homer R, Ray A, Ray P. Essential role of nuclear kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med. 1998;188:1739-1750.
36. Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 1995;80:321-330.
37. Das J, Chen CH, Yang L, Cohn L, Ray P, Ray A. A critical role for NF-kappa B in GATA-3 expression and Th2 differentiation in allergic airway inflammation. Nat Immunol. 2001;1:45-50.
38. Shen CH, Stavenezer J. Interaction of STAT6 and NF-κB: direct association and synergistic activation of interleukin-4 induced transcription. Mol Cell Biol. 1998;18:3395-3404.
39. Stutz AM, Woisetschlager M. Functional synergism of STA6 with either NF-κB or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription. J Immunol. 1999;163:4383-4391.
40. Yanagihara Y, Basaki Y, Ikizawa K, Kajiwara K, Koshio T, Akiyama K. Involvement of nuclear factor-kappa B activation in IgE synthesis in human B cells. J Allergy Clin Immunol. 1996;98:S224-229.
41. Kuperman DA, Huang X, Koth LL, et al. Direct effect of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med. 2002;8:885-889.